Johan Hellgren

1 – 4 of 4

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/8d52612c-1375-43c8-8f0b-e21ac5923853?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2025
Mark Comparison of CSF biomarkers in multiple sclerosis patients treated with natalizumab and rituximab
Hellgren, Johan ^LU ; Ahlström, Isabella ; Strandberg, Maria Compagno ^LU ; Jonsson, Magnus Förnvik ^LU ; Hansson, Oskar ^LU ; Janelidze, Shorena ^LU ; Svenningsson, Anders and Källén, Kristina ^LU (2025) In Multiple Sclerosis and Related Disorders 99.
- Contribution to journal › Article
Mark Rituximab in multiple sclerosis - Fatigue, cognition, and efficacy
Hellgren, Johan ^LU (2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
2024
Mark A comparative study of fatigue and processing speed in patients with multiple sclerosis treated with natalizumab or rituximab
Hellgren, Johan ^LU ; Strandberg, Maria Compagno ^LU ; Källén, Kristina ^LU and Svenningsson, Anders (2024) In Multiple Sclerosis Journal - Experimental, Translational and Clinical 10(2).
- Contribution to journal › Article
2020
Mark Rituximab in multiple sclerosis at general hospital level
Hellgren, Johan ^LU ; Risedal, Anette ^LU and Kallen, Kristina ^LU (2020) In Acta Neurologica Scandinavica 141(6). p.491-499
- Contribution to journal › Article